NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Mphasis Shifts Operating Model, Launches Enterprise AI Platform

Mphasis, a leading digital transformation company, is undergoing a significant transformation of its operating model. The company is shifting away from traditional services and towards a combination of subscription/Annual Recurring Revenue (ARR) + implementation + managed service model. This new operating model aims to scale to 20-30% revenue mix in the medium term.

Key Developments

Mphasis has launched Mphasis Tria, its new enterprise AI platform, designed to capture institutional memories and derive ontologies on top. This platform-led service approach is expected to drive business accountability, ownership, and enterprise AI governance, thereby de-risking business outcomes and scaling AI transition. The company highlighted strong deal traction, with its pipeline growing 4x over 18 months.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Deal Traction and Mix

The company's large deal (USD 100m+) concentration mix has improved notably to 29% in FY26 compared to 18% in FY25. As a result, the average deal size has also improved to USD 75m in FY26 from USD 54m in FY25. Mphasis is doubling down on consolidation deals and gaining wallet share on blue-chip accounts.

Outlook and Risks

While the company's deal construct is growth and margin supportive, it is backed by upfront capital allocations and measured risk tied to scaling presumptions. However, there is a downside risk to cash conversion (FY27E/FY28E) if a similar deal construct were to escalate going forward.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Recommendation

We maintain our revenue and margin estimates for FY27E & FY28E. Reiterate our BUY rating with an unchanged Target Price (TP) of INR 3,000.

FY26FY25
Large Deal (USD 100m+) Concentration Mix (%)29%
Average Deal Size (USD)75m
Pipeline Growth (18 months)4x

Investor Takeaway

Investors should consider Mphasis as a potential growth stock with a scalable business model.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.